SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Valion Bio’s Entolimod Enters U.S.-Funded GI-ARS Efficacy Study

NIAID and AFRRI will run a fully funded efficacy study of Entolimod in a GI-ARS mouse model. Top-line results are expected in early December, following positive safety findings.

VBIO

Related stories